Oral Lichen Planus. Lichen planus
Conditions
Interventions
Intervention 1: Control group G 1: Control side in group A will be received topical 0.1% triamcinolone acetonide suspension (Exir, Iran) twice a day as the first line treatment during the study (for t
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Subjects aged 18 years or older Subjects diagnosed with OLP based on the clinical or histopathological findings according to the newest diagnostic approach published by American Academy of Oral and Maxillofacial Pathology in ???? Subjects with bilateral symptomatic OLP lesions Subjects who are willing to complete this clinical trial
Exclusion criteria
Exclusion criteria: Subjects with lesions that may be associated with lichenoid reactions Subjects having a history of drug allergy Subjects with a history of use of topical corticosteroids (in the past ? weeks) or systemic corticosteroids (in the past ? months) for oral lichen planus, other immunosuppressive treatments, retinoids, and anticoagulants Subjects having oral candidiasis Subjects with self-reported pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Level. Timepoint: At the beginning of the study (before the start of the intervention) and 14, 28, and 56 days after start. Method of measurement: Visual Analogue Scale.;Severity of the lesions. Timepoint: At the beginning of the study (before the start of the intervention) and 14, 28, and 56 days after start. Method of measurement: reticulation/erythema/ ulceration (REU) scoring system. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAsma Sookhakian
Shiraz University of Medical Sciences
Outcome results
None listed